(Q40921369)

24 September 2017

title

Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1. (English)

1 reference

24 September 2017

0 references

1 reference

Prang N

1

1 reference

24 September 2017

Wolf H

series ordinal

2

1 reference

24 September 2017

Schwarzmann F

series ordinal

3

1 reference

24 September 2017

publication date

1 December 1999

1 reference

Journal of Medical Virology

24 September 2017

published in

1 reference

24 September 2017

volume

59

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

512-519

1 reference

Early events in Epstein-Barr virus infection of human B lymphocytes

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Herpes simplex virus latency-associated transcript is a stable intron

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

The BI'LF4 trans-activator of Epstein-Barr virus is modulated by type and differentiation of the host cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

What makes an mRNA anti-sense-itive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

Targeting frequency for deletion vectors in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199912%2959%3A4%3C512%3A%3AAID-JMV15%3E3.0.CO%3B2-B

10.1002/(SICI)1096-9071(199912)59:4<512::AID-JMV15>3.0.CO;2-B

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference